Lars Rebien Sørensen
Director/Board Member at THERMO FISHER SCIENTIFIC
Net worth: 5 M $ as of 29/04/2024
Network origin in Lars Rebien Sørensen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Medical Specialties | 123 | |
114
| Public Company | Pharmaceuticals: Major | 114 |
| Private Company | Movies/Entertainment | 45 | |
Copenhagen Business School
38
| College/University | Other Consumer Services | 38 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
34
| Extinct | Pharmaceuticals: Major | 34 |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark.
28
| Foundation/Endowment | Investment Trusts/Mutual Funds | 28 |
University of Copenhagen
26
| College/University | Other Consumer Services | 26 |
24
| Public Company | Electric Utilities | 24 |
| Public Company | Beverages: Alcoholic | 22 | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.
20
| Subsidiary | Financial Conglomerates | 20 |
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark.
11
| Subsidiary | Beverages: Alcoholic | 11 |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland.
9
| Private Company | Pharmaceuticals: Major | 9 |
Novo Nordisk (Private Equity)
 Novo Nordisk (Private Equity) Investment ManagersFinance Novo Nordisk A/S (CO: NOVO.B; NYSE: NVO), a Danish healthcare company which manufactures and markets pharmaceutical products and services worldwide, invests through their corporate venture fund NNBF-Novo Nordisk Biotech Fund (NNBF). Based in Bagsværd near Copenhagen, NNBF is a business unit within Novo Nordisk A/S, responsible for the company's venture capital activities. Investments are made on the books of Novo Nordisk A/S out of internal financial resources. NNBF is managed as an evergreen fund.
3
| Extinct | Investment Managers | 3 |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets.
3
| Operating Division | Financial Conglomerates | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lars Rebien Sørensen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer | |
Ferring Pharmaceuticals Ltd.
 Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
Bertelsmann Management SE
 Bertelsmann Management SE Miscellaneous Commercial ServicesCommercial Services Bertelsmann Management SE is an international media enterprise with corporate divisions including RTL Group, Penguin Random House, and Gruner + Jahr. The private company is based in Gütersloh, DE and has a global presence of subsidiaries in several regions. The German company's Press Center provides detailed information for journalists, and the company is also committed to Corporate Responsibility activities. Thomas Hermann Rabe has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
| NNIT A/S | Information Technology Services | Chairman Director/Board Member Corporate Officer/Principal Director/Board Member | |
| University of Aarhus | College/University | Graduate Degree Director/Board Member Graduate Degree Graduate Degree | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| DANSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member Director/Board Member President | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President Director of Finance/CFO President | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
Ferring GmbH
 Ferring GmbH Pharmaceuticals: MajorHealth Technology Ferring GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Kiel, Germany. The company was founded in 1990. The CEO is Claus Tollnick. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor | |
Moelis & Co. (UK) LLP
 Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Corporate Officer/Principal Chief Executive Officer | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Sales & Marketing Chairman Corporate Officer/Principal | |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Medical/Nursing ServicesHealth Services Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member | |
Ferring Pharmaceuticals SA
 Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Biotechnology | Director/Board Member President Director/Board Member | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| State University of New York at Buffalo | College/University | Doctorate Degree Doctorate Degree | |
Druck- & Verlagshaus Hüpke & Sohn Weserland-Verlag GmbH
 Druck- & Verlagshaus Hüpke & Sohn Weserland-Verlag GmbH Publishing: NewspapersConsumer Services Druck- & Verlagshaus Hüpke & Sohn Weserland-Verlag GmbH engages in the publishing and distribution of newspapers. It provides reports about local and global news, politics, business, sports, medicine, and health. It also offers online news reports as well as advertising and subscription services. The company was founded in 1777 and is headquartered in Holzminden, Germany. | Publishing: Newspapers | Chairman Chairman | |
| University of Southern Denmark | College/University | Corporate Officer/Principal Graduate Degree | |
| RTL GROUP S.A. | Broadcasting | Chief Executive Officer Director/Board Member | |
FinVector Oy
 FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Carlsberg Byen P/S
 Carlsberg Byen P/S Real Estate DevelopmentFinance Carlsberg Byen P/S engages in real estate development. It develops residential, commercial, retail, culture, sport, and institutions. The company was founded on August 2013 and is headquartered in Copenhagen, Denmark. | Real Estate Development | Director/Board Member Director/Board Member | |
| ADIDAS AG | Apparel/Footwear | Chairman Director/Board Member | |
| Trizell Holding SA | Director/Board Member Founder | ||
| CONVATEC GROUP PLC | Medical Specialties | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Ferring Laboratories Ltd.
 Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company is based in Middlesex, UK and was founded in 1980. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SCHLUMBERGER AG | Beverages: Alcoholic | Director/Board Member Chairman | |
| University of Kiel | College/University | Doctorate Degree Director/Board Member | |
| Technical University of Denmark | College/University | Chairman Graduate Degree | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Leiden | College/University | Graduate Degree Graduate Degree | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin | |
Gruner + Jahr Deutschland GmbH
 Gruner + Jahr Deutschland GmbH Publishing: Books/MagazinesConsumer Services Gruner + Jahr Deutschland GmbH publishes printed and digital media products. The company distributes premium magazines under the STERN, GEO, BRIGITTE, ESSEN & TRINKEN, SCHÖNER WOHNEN, CHEFKOCH, BARBARA, BEEF, and 11FREUNDE brands. It also operates the international digital marketing platform AppLike. The company was founded by John Jahr, Sr., John Jahr, Gerd Bucerius, and Richard Gruner on June 30, 1965 and is headquartered in Hamburg, Germany. | Publishing: Books/Magazines | Chairman Chairman | |
| NESTLÉ S.A. | Food: Major Diversified | Chief Operating Officer Corporate Officer/Principal |
Statistics
International
| Denmark | 17 |
| United States | 11 |
| United Kingdom | 7 |
| Germany | 7 |
| Switzerland | 4 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 15 |
| Finance | 6 |
| Consumer Non-Durables | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 695 |
| Chairman | 226 |
| Corporate Officer/Principal | 198 |
| Independent Dir/Board Member | 152 |
| Chief Executive Officer | 86 |
Most connected contacts
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Göran Albert Ando | 44 |
| Scott Sperling | 40 |
| Jørn Peter Jensen | 37 |
| Thomas Hermann Rabe | 33 |
| Hans Dieter Pötsch | 32 |
| Sten Scheibye | 31 |
| Hélène Ploix | 31 |
| Bodo Knut Uebber | 30 |
| Nanna Liebach Lüneborg | 29 |
| Lilian Biner | 29 |
| Jesper Brandgaard | 28 |
| Sylvie Grégoire | 25 |
| Bruce Carter | 25 |
| Douglas Williams | 25 |
- Stock Market
- Insiders
- Lars Rebien Sørensen
- Company connections
